表紙
市場調查報告書

兒童遺傳基因檢驗的全球市場:2020∼2030年

Global Pediatric Genetic Testing Market: Focus on Origin, Sample Type, Product Type, Disease Type, Technologies, Application Area, Country Data (15 countries) - Analysis and Forecast, 2020-2030

出版商 BIS Research Inc. 商品編碼 954173
出版日期 內容資訊 英文 210 Pages
商品交期: 最快1-2個工作天內
價格
兒童遺傳基因檢驗的全球市場:2020∼2030年 Global Pediatric Genetic Testing Market: Focus on Origin, Sample Type, Product Type, Disease Type, Technologies, Application Area, Country Data (15 countries) - Analysis and Forecast, 2020-2030
出版日期: 2020年08月13日內容資訊: 英文 210 Pages
簡介

全球兒童遺傳基因檢驗的市場在預測期間內預計以14.30%的年複合成長率發展,從2019年的27億8280萬美元,成長到2030年120億6320萬美元的規模。政府舉措的擴大,一般市民對遺傳疾病的認識度提高,分子診斷的進步,基因諮詢顧問的增加等要素促進該市場成長。

本報告提供全球兒童遺傳基因檢驗的市場調查,市場定義和概要,COVID-19以及其他的市場影響因素分析,相關法律,市場規模的變化、預測,檢體、產品類型、原因、疾病區分、用途、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 產品定義

第2章 調查範圍

第3章 調查手法

第4章 市場概要

  • 市場方案
  • 主要的遺傳基因檢驗技術
  • COVID-19的影響

第5章 產業分析

  • 概要
  • 法律上的必要條件、架構:美國
  • 法律上的必要條件、架構:歐洲
  • 法律規章:亞太地區
  • 專利分析

第6章 競爭情形

  • 主要的展開、策略
  • 新的產品、服務
  • 具協同效應的配合措施
  • 產品核可
  • 事業擴大
  • 市場佔有率分析
  • 成長佔有率分析

第7章 市場動態

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第8章 市場分析、預測:各檢體

  • 概要
  • 血液
  • 唾液
  • 組織
  • 骨髓

第9章 市場分析、預測:各產品類型

  • 概要
  • 套件
  • 實驗室開發試驗(LDT)
  • 試劑

第10章 市場分析、預測:各原因

  • 概要
  • 身體疾病
  • 遺傳性疾病

第11章 市場分析、預測:各疾病種類

  • 概要
  • 發育障礙
  • 神經學的障礙
  • 心血管疾病
  • 其他

第12章 市場分析、預測:各技術

  • 概要
  • 序列
  • PCR (聚合酵素鏈鎖反應)
  • In Situ雜合反應(ISH/FISH)
  • 微陣列技術

第13章 市場分析、預測:各用途

  • 概要
  • 臨床診斷
  • 監測、篩檢
  • 藥物研發
  • 學術、研究

第14章 市場分析、預測:各地區、主要國家

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 其他地區

第15章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BGI Genomics
  • Baebies
  • CENTOGENE AG
  • Fulgent Genetics, Inc.
  • Genomic Diagnostics
  • Invitae Corporation
  • LifeCell International Pvt. Ltd.
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Unilabs
目錄
Product Code: BHP0941SA

"Global Pediatric Genetic Testing Market to Reach $12.06 Billion by 2030."

Market Report Coverage - Pediatric Genetic Testing

Market Segmentation

  • By Origin: Somatic Disorders and Inherited Disorders
  • By Sample Type: Tissue, Bone Marrow, Blood, Saliva
  • By Product Type: Kits, LDT Tests, Reagents
  • By Disease Type: Neurological Disorders, Cardiac Disorders, Developmental Disorders, Others
  • By Application Area: Academic and Research, Clinical Diagnostics, Drug Discovery, Monitoring, and Screening
  • By Region: North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Rest-of-Europe
  • Asia-Pacific - Japan, China, India, Australia, South Korea, Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico, Rest-of-Latin America
  • Rest-of-the-World

Growth Drivers

  • Significant Number of Pediatric Genetic Disorders causing Birth Defects and Deaths
  • A Decrease in Cost of Genetic Testing Globally
  • Advancements within Molecular Techniques for Clinical Diagnostics

Market Challenges

  • Challenging Regulatory Scenario
  • Uncertainty in Reimbursement of Genetic Testing

Market Opportunities

  • Increasing Awareness for Newborn Genetic Testing and Counseling
  • Rising Funding and Innovations

Key Companies Profiled

Abbott Laboratories, Invitae Corporation, Fulgent Genetics., Agilent Technologies, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Genomic Diagnostics, Unilabs, LifeCell International Pvt. Ltd., Trivitron Healthcare and Baebies, Inc.

Key Questions Answered in this Report:

  • What are the initiatives implemented by different government bodies regulating the development and commercialization of genetic testing products and services?
  • What are the leading companies dominating the global pediatric genetic testing market?
  • What are the upcoming technologies that can take over the current technologies for pediatric genetic testing?
  • What is the reimbursement scenario of the products offered in the global pediatric genetic testing market?
  • What is the average cost of available technologies in pediatric genetic testing?
  • Based on the application, which pediatric genetic testing application is anticipated to witness a massive rise in demand in the forecast period?
  • What was the market value in 2019 of the leading segments and sub-segments of the global pediatric genetic testing market?
  • How is each segment of the global pediatric genetic testing market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2030?
  • How is the industry anticipated to evolve during the forecast period 2020-2030?
  • Which region is expected to contribute to the highest sales of the global pediatrics genetic testing market during the forecast period?
  • What are the leading trends and consumer preferences witnessed in the global pediatric genetic testing markets?

Market Overview

Genetic testing within the newborns, infants, and adolescents is performed to identify the cause of developmental delay, multiple malformations, intellectual disability, and dysmorphic features, among others. The genetic tests are also used to rule out chromosomal abnormalities and single genes via various molecular and cytogenetic genetic techniques. These tests further can help the parents understand the reason behind the disorders and also manage the disease at an early stage.

The global pediatrics genetic testing market was valued $2,782.8 million in 2019, and it is expected to grow at an impressive double-digit rate of 14.30% and reach a value of 12,063.2 million in 2030.

The existing pediatric genetic testing market is favored by multiple factors, which include rising government initiatives, coupled up with the general population's growing awareness pertaining to genetic conditions. Additionally, the increasing number of advancements in molecular diagnostics, more genetic counselors are some of the key driving factors for the pediatric genetic testing market.

Within the research report, the market is segmented on the basis of origin (somatic disorders and hereditary disorders ), sample type (tissue, bone marrow, blood and saliva), product type (kits, LDT tests, and reagents), disease type (neurological disorder, cardiac disorder, developmental disorder, and others), application area (academic and research, clinical diagnostics, drug discovery and monitoring and screening), and region (North America, Europe, Asia Pacific, Latin America, and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.

Competitive Landscape

The pediatric genetic testing market has witnessed 16 product offerings, two product approvals, nine partnerships and alliances, two mergers and acquisitions, and four business expansions in the past five years (January 2015- May 2020).

Major players within the pediatric genetic testing market are Quest Diagnostics, Centogene AG, Opko Health, Inc., Eurofins Scientific, Abbott Laboratories, Invitae Corporation, Fulgent Genetics., Agilent Technologies, Inc., PerkinElmer, Inc., Thermofisher Scientific, Genomic Diagnostics, Unilabs, LifeCell International Pvt. Ltd., Trivitron Healthcare and Baebies, Inc.

Table of Contents

1. Product Definition

  • 1.1. Inclusion and Exclusion

2. Scope of Research Study

  • 2.1. Research Scope
  • 2.2. Key Questions Answered by the Research Study

3. Research Methodology

  • 3.1. Primary Research
  • 3.2. Secondary Research
  • 3.3. Data Sources Categorization
  • 3.4. Assumptions and Limitations
  • 3.5. Criteria for Company Profiles Selection

4. Market Overview

  • 4.1. Global Pediatric Genetic Testing Market Scenario
  • 4.2. Genetic Testing Technologies Opted by Pediatrics
    • 4.2.1. Technologies for Gene Testing in Children
      • 4.2.1.1. Chromosome Analysis
        • 4.2.1.1.1. Unmet Needs
      • 4.2.1.2. Fluorescence in situ hybridization (FISH)
        • 4.2.1.2.1. Unmet Needs
      • 4.2.1.3. Chromosomal Microarray
        • 4.2.1.3.1. Unmet Needs
      • 4.2.1.4. PCR (DNA) Fragment Size Analysis
        • 4.2.1.4.1. Unmet Needs
      • 4.2.1.5. Single-Gene Analysis by Sanger Sequencing
        • 4.2.1.5.1. Unmet Needs
      • 4.2.1.6. Next-Generation Sequencing
        • 4.2.1.6.1. Unmet Needs
      • 4.2.1.7. Emerging Technologies
  • 4.3. Impact of COVID-19 Pandemic on Genetic Testing Market

5. Industry Analysis

  • 5.1. Overview
  • 5.2. Legal Requirements and Framework in the U.S.
  • 5.3. Legal Requirements and Framework in Europe
    • 5.3.1. Germany
    • 5.3.2. France
    • 5.3.3. U.K.
    • 5.3.4. Spain
  • 5.4. Regulation in APAC
    • 5.4.1. China
    • 5.4.2. Japan
    • 5.4.3. South-Korea
  • 5.5. Patent Analysis

6. Competitive Landscape

  • 6.1. Key Developments and Strategies
  • 6.2. New Offerings
  • 6.3. Synergistic Activities
  • 6.4. Product Approval
  • 6.5. Business Expansion
  • 6.6. Market Share Analysis
  • 6.7. Growth-Share Analysis

7. Market Dynamics

  • 7.1. Market Drivers
    • 7.1.1. Significant Number of Pediatric Genetic Disorders causing Birth Defects and Deaths
    • 7.1.2. Decreasing Cost of Genetic Testing Globally
    • 7.1.3. Decrease in Overall Cost and Time of Care
    • 7.1.4. Advancements within Molecular Techniques for Clinical Diagnostics
  • 7.2. Market Restrains
    • 7.2.1. Challenging Regulatory Scenario
    • 7.2.2. Uncertainty in Reimbursement of Genetic Testing
  • 7.3. Market Opportunities
    • 7.3.1. Increasing Awareness for Newborn Genetic Testing and Counseling
    • 7.3.2. Rising Funding and Innovations

8. Global Pediatric Genetic Testing Market, (by Sample Type)

  • 8.1. Overview
  • 8.2. Blood
  • 8.3. Saliva
  • 8.4. Tissue
  • 8.5. Bone Marrow

9. Global Pediatric Genetic Testing Market, (by Product Type)

  • 9.1. Overview
  • 9.2. Kits
  • 9.3. Laboratory Developed Tests (LDT)
  • 9.4. Reagents

10. Global Pediatric Genetic Testing Market, (by Origin)

  • 10.1. Overview
  • 10.2. Somatic Disorders
  • 10.3. Inherited Disorders

11. Global Pediatric Genetic Testing Market, (by Disorder Type)

  • 11.1. Overview
  • 11.2. Developmental Disorders
  • 11.3. Neurological Disorders
  • 11.4. Cardiovascular Disorders
  • 11.5. Others

12. Global Pediatric Genetic Testing Market, (by Technology)

  • 12.1. Overview
  • 12.2. Sequencing
  • 12.3. Polymerase Chain Reaction
  • 12.4. In Situ Hybridization (ISH/FISH)
  • 12.5. Microarray Techniques

13. Global Pediatric Genetic Testing Market, (by Application Area)

  • 13.1. Overview
  • 13.2. Clinical Diagnostics
  • 13.3. Monitoring and Screening
  • 13.4. Drug Discovery
  • 13.5. Academic and Research

14. Global Pediatric Genetic Testing Market, (by Region)

  • 14.1. Overview
  • 14.2. North America
    • 14.2.1. U.S.
    • 14.2.2. Canada
  • 14.3. Europe
    • 14.3.1. Germany
    • 14.3.2. U.K.
    • 14.3.3. France
    • 14.3.4. Italy
    • 14.3.5. Spain
    • 14.3.6. Rest-of-Europe
  • 14.4. Asia-Pacific
    • 14.4.1. Japan
    • 14.4.2. China
    • 14.4.3. India
    • 14.4.4. Australia
    • 14.4.5. South-Korea
    • 14.4.6. Rest-of-Asia-Pacific
  • 14.5. Latin America
    • 14.5.1. Brazil
    • 14.5.2. Mexico
    • 14.5.3. Rest-of-Latin America
  • 14.6. Rest-of-the-World

15. Company Profiles

  • 15.1. Abbott Laboratories
    • 15.1.1. Company Overview
    • 15.1.2. Role of Abbott Laboratories in the Global Pediatric Genetic Testing Market
    • 15.1.3. Financials
    • 15.1.4. SWOT Analysis
  • 15.2. Agilent Technologies, Inc.
    • 15.2.1. Company Overview
    • 15.2.2. Role of Agilent Technologies, Inc. in the Global Pediatric Genetic Testing Market
    • 15.2.3. Financials
    • 15.2.4. SWOT Analysis
  • 15.3. BGI Genomics
    • 15.3.1. Company Overview
    • 15.3.2. Role of BGI Genomics in the Global Pediatric Genetic Testing Market
    • 15.3.3. SWOT Analysis
  • 15.4. Baebies
    • 15.4.1. Company Overview
    • 15.4.2. Role of Baebies in the Global Pediatric Genetic Testing Market
    • 15.4.3. SWOT Analysis
  • 15.5. CENTOGENE AG
    • 15.5.1. Company Overview
    • 15.5.2. Role of Centogene AG in the Global Pediatric Genetic Testing Market
    • 15.5.3. SWOT Analysis
  • 15.6. Fulgent Genetics, Inc.
    • 15.6.1. Company Overview
    • 15.6.2. Role of Fulgent Genetics, Inc. in the Global Pediatric Genetic Testing Market
    • 15.6.3. Financials
    • 15.6.4. SWOT Analysis
  • 15.7. Genomic Diagnostics
    • 15.7.1. Company Overview
    • 15.7.2. Role of Genomic Diagnostics in the Global Pediatric Genetic Testing Market
    • 15.7.3. SWOT Analysis
  • 15.8. Invitae Corporation
    • 15.8.1. Company Overview
    • 15.8.2. Role of Invitae Corporation in the Global Pediatric Genetic Testing Market
    • 15.8.3. Financials
    • 15.8.4. SWOT Analysis
  • 15.9. LifeCell International Pvt. Ltd.
    • 15.9.1. Company Overview
    • 15.9.2. Role of Life Cell International Pvt. Ltd. in the Global Pediatric Genetic Testing Market
    • 15.9.3. SWOT Analysis
  • 15.1. OPKO Health, Inc.
    • 15.10.1. Company Overview
    • 15.10.2. Role of OPKO Health, Inc. in the Global Pediatric Genetic Testing Market
    • 15.10.3. Financials
    • 15.10.4. SWOT Analysis
  • 15.11. PerkinElmer, Inc.
    • 15.11.1. Company Overview
    • 15.11.2. Role of PerkinElmer, Inc. in the Global Pediatric Genetic Testing Market
    • 15.11.3. Financials
    • 15.11.4. SWOT Analysis
  • 15.12. Quest Diagnostics
    • 15.12.1. Company Overview
    • 15.12.2. Role of Quest Diagnostics in the Global Pediatric Genetic Testing Market
    • 15.12.3. Financials
    • 15.12.4. SWOT Analysis
  • 15.13. Thermo Fisher Scientific Inc.
    • 15.13.1. Company Overview
    • 15.13.2. Role of Thermo Fisher Scientific Inc.in the Global Pediatric Genetic Testing Market
    • 15.13.3. Financials
    • 15.13.4. SWOT Analysis
  • 15.14. Trivitron Healthcare
    • 15.14.1. Company Overview
    • 15.14.2. Role of Trivitron Healthcare in the Global Pediatric Genetic Testing Market
    • 15.14.3. SWOT Analysis
  • 15.15. Unilabs
    • 15.15.1. Company Overview
    • 15.15.2. Role of Unilabs in the Global Pediatric Genetic Testing Market
    • 15.15.3. SWOT Analysis

List of Tables

  • Table 5.1: Regulatory Bodies Governing Genetic Testing

List of Figures

  • Figure 1: Number of Deaths due to Down Syndrome, 2012-2015
  • Figure 2: Global Pediatric Genetic Testing Market, 2019 and 2030
  • Figure 3: Market Drivers, Market Opportunities and Market Restraints
  • Figure 4: Share of Key Developments and Strategies, January 2015-May 2020
  • Figure 5: Growth Share Matrix for Global Pediatric Genetic Testing Market (by Company), 2018
  • Figure 6: Share of Global Pediatric Genetic Testing Market (by Technology), 2019-2030
  • Figure 7: Global Pediatric Genetic Testing Market (by Region), 2019 and 2030
  • Figure 2.1: Global Pediatric Genetic Testing Market Segmentation
  • Figure 3.1: Global Pediatric Genetic Testing Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Share of Total Number of Companies Profiled
  • Figure 4.1: Global Pediatric Genetic Testing Market, 2019-2030
  • Figure 4.2: Diagnostic Approach for Newborns with Multiple Congenital Anomalies
  • Figure 4.3: Positive and Negative Impact of COVID-19 on Pediatric Genetic Testing Market
  • Figure 5.1: Total Patents Filed, by Technology (2015-2018)
  • Figure 6.1: Share of Key Developments and Strategies, January 2015-May 2020
  • Figure 6.2: New Offerings and Product Approval Share (by Company), January 2015-May 2020
  • Figure 6.3: Synergistic Activities Share (by Company), January 2015- May 2020
  • Figure 6.4: Product Approval Share (by Company), January 2015-May 2020
  • Figure 6.5: Business Expansion Activities (by Company), January 2015- May 2020
  • Figure 6.6: Market Share Analysis of Pediatric Genetic Testing Market (by Company), 2019
  • Figure 6.7: Growth Share Matrix for Global Pediatric Genetic Testing Market (by Company), 2018
  • Figure 7.1: Impact of Market Drivers and Restraints on Global Pediatric Genetic Testing, 2019-2030
  • Figure 8.1: Share of Global Pediatric Genetic Testing Market (by Sample Type), 2019-2030
  • Figure 8.2: Global Pediatric Genetic Testing Market (by Blood Sample), 2019-2030
  • Figure 8.3: Global Pediatric Genetic Testing Market (by Saliva Sample), 2019-2030
  • Figure 8.4: Global Pediatric Genetic Testing Market (by Tissue Sample), 2019-2030
  • Figure 8.5: Global Pediatric Genetic Testing Market (by Bone Marrow Sample), 2019-2030
  • Figure 9.1: Share of Global Pediatric Genetic Testing Market (by Product Type), 2019-2030
  • Figure 9.2: Pediatric Genetic Testing Market (by Kits), 2019-2030
  • Figure 9.3: Pediatric Genetic Testing Market (by LDT), 2019-2030
  • Figure 9.4: Pediatric Genetic Testing Market (by Reagents), 2019-2030
  • Figure 10.1: Share of Global Pediatric Genetic Testing Market (by Origin), 2019-2030
  • Figure 10.2: Pediatric Genetic Testing Market (by Somatic Disorder), 2019-2030
  • Figure 10.3: Pediatric Genetic Testing Market (by Inherited Disorder), 2019-2030
  • Figure 11.1: Share of Global Pediatric Genetic Testing Market (by Disorder Type), 2019-2030
  • Figure 11.2: Global Pediatric Genetic Testing Market (by Developmental Disorder), 2019-2030
  • Figure 11.3: Global Pediatric Genetic Testing Market (by Neurological Disorder), 2019-2030
  • Figure 11.4: Global Pediatric Genetic Testing Market (by Cardiovascular Disorder), 2019 2030
  • Figure 11.5: Global Pediatric Genetic Testing Market (by Others), 2019 2030
  • Figure 12.1: Share of Global Pediatric Genetic Testing Market (by Technology), 2019-2030
  • Figure 12.2: Global Pediatric Genetic Testing Market (by Sequencing), 2019-2030
  • Figure 12.3: Global Pediatric Genetic Testing Market (by PCR), 2019-2030
  • Figure 12.4: Global Pediatric Genetic Testing Market (by ISH), 2019-2030
  • Figure 12.5: Global Pediatric Genetic Testing Market (by Microarray), 2019-2030
  • Figure 13.1: Share of Global Pediatric Genetic Testing Market (by Application), 2019-2030
  • Figure 13.2: Global Pediatric Genetic Testing Market (by Clinical Diagnostics), 2019-2030
  • Figure 13.3: Global Pediatric Genetic Testing Market (by Monitoring and Screening), 2019-2030
  • Figure 13.4: Global Pediatric Genetic Testing Market (by Drug Discovery), 2019-2030
  • Figure 13.5: Global Pediatric Genetic Testing Market (by Academic and Research), 2019-2030
  • Figure 14.1: Global Pediatric Genetic Testing Market (by Region), 2019 and 2030
  • Figure 14.2: North America: Market Dynamics
  • Figure 14.3 : North America Pediatric Genetic Testing Market (by Country), 2019-2030
  • Figure 14.4: U.S. Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.5: Canada Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.6: Europe Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.7: Europe: Market Dynamics
  • Figure 14.8: Europe Pediatric Genetic Testing Market (by Country), 2019-2030
  • Figure 14.9: Number of Live Births in Germany (2012-2018)
  • Figure 14.10: Germany Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.11: U.K. Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.12: France Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.13: Italy Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.14: Spain Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.15: Rest-of-Europe Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.16: Asia-Pacific Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.17: Asia-Pacific: Market Dynamics
  • Figure 14.18: Asia-Pacific Pediatric Genetic Testing Market (by Country), 2019-2030
  • Figure 14.19: Total Live Births with Down's Syndrome in Japan, (2012-2016)
  • Figure 14.20: Japan Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.21: China Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.22: India Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.23: Australia Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.24: South-Korea Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.25: Rest-of-Asia-Pacific Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.26: Latin America Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.27: Latin America: Market Dynamics
  • Figure 14.28: Latin America Global Pediatric Genetic Testing Market (by Country), 2019 and 2030
  • Figure 14.29: Brazil Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.30: Mexico Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.31: Rest-of-Latin-America Pediatric Genetic Testing Market, 2019-2030
  • Figure 14.32: Rest-of-the-World Pediatric Genetic Testing Market, 2019-2030
  • Figure 15.1: Abbott Laboratories.: Overall Product Offerings
  • Figure 15.2: Abbott Laboratories: Overall Financials, 2016-2018
  • Figure 15.3: Abbott Laboratories: Net Revenue (by Business Segment), 2017-2019
  • Figure 15.4: Abbott Laboratories: Net Revenue (by Region), 2017-2019
  • Figure 15.5: Abbott Laboratories: Research and Development Expense, 2017-2019
  • Figure 15.6: Abbott Laboratories: SWOT Analysis
  • Figure 15.7: Agilent Technologies, Inc..: Overall Product Offerings
  • Figure 15.8: Agilent Technologies, Inc.: Overall Financials, 2017-2019
  • Figure 15.9: Agilent Technologies, Inc.: Net Revenue (by Business Segment), 2016-2018
  • Figure 15.10: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
  • Figure 15.11: Agilent Technologies, Inc.: Research and Development Expense, 2017-2019
  • Figure 15.12: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 15.13: BGI Genomics.: Overall Product Offerings
  • Figure 15.14: BGI Genomics: SWOT Analysis
  • Figure 15.15: Baebies: Overall Product Offerings
  • Figure 15.16: Baebies: SWOT Analysis
  • Figure 15.17: Centogene AG: Overall Product Offerings
  • Figure 15.18: Centogene AG: SWOT Analysis
  • Figure 15.19: Fulgent Genetics, Inc..: Overall Product Offerings
  • Figure 15.20: Fulgent Genetics, Inc.: Overall Financials, 2017-2019
  • Figure 15.21: Fulgent Genetics, Inc.: Net Revenue (by Region), 2017-2019
  • Figure 15.22: Fulgent Genetics, Inc.: Research and Development Expense, 2017-2019
  • Figure 15.23: Fulgent Genetics, Inc.: SWOT Analysis
  • Figure 15.24: Genomic Diagnostics: Overall Product Offerings
  • Figure 15.25: Genomic Diagnostics: SWOT Analysis
  • Figure 15.26: Invitae Corporation: Overall Product Offerings
  • Figure 15.27: Invitae Corporation: Overall Financials, 2017-2019
  • Figure 15.28: Invitae Corporation: Revenue (by Segment), 2017-2019
  • Figure 15.29: Invitae Corporation: Revenue (by Region), 2017-2019
  • Figure 15.30: Invitae Corporation: R&D Expenditure, 2017-2019
  • Figure 15.31: Invitae Corporation: SWOT Analysis
  • Figure 15.32: LifeCell International Pvt. Ltd.: Overall Product Offerings
  • Figure 15.33: LifeCell International Pvt. Ltd.: SWOT Analysis
  • Figure 15.34: OPKO Health, Inc.: Overall Product Offerings
  • Figure 15.35: OPKO Health, Inc.: Overall Financials, 2017-2019
  • Figure 15.36: OPKO Health, Inc: Net Revenue (by Business Segment), 2016-2018
  • Figure 15.37: OPKO Health, Inc.: Net Revenue (by Region), 2017-2019
  • Figure 15.38: OPKO Health, Inc.: Research and Development Expense, 2017-2019
  • Figure 15.39: OPKO Health, Inc.: SWOT Analysis
  • Figure 15.40: PerkinElmer, Inc.: Overall Product Offerings
  • Figure 15.41: PerkinElmer, Inc: Overall Financials, 2017-2019
  • Figure 15.42: PerkinElmer, Inc.: Revenue (by Segment), 2017-2019
  • Figure 15.43: PerkinElmer, Inc.: R&D Expenditure, 2017-2019
  • Figure 15.44: PerkinElmer, Inc.: SWOT Analysis
  • Figure 15.45: Quest Diagnostics Incorporated: Overall Product Offerings
  • Figure 15.46: Quest Diagnostics Incorporated: Overall Financials, 2017-2019
  • Figure 15.47: Quest Diagnostics Incorporated: Revenue (by Business Segment), 2017-2019
  • Figure 15.48: Quest Diagnostics Incorporated: SWOT Analysis
  • Figure 15.49 Thermo Fisher Scientific Inc.: Overall Product Offerings
  • Figure 15.50: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
  • Figure 15.51: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2017-2019
  • Figure 15.52: Thermo Fisher Scientific Inc.: Revenue (by Geography), 2017-2019
  • Figure 15.53: Thermo Fisher Scientific Inc: R&D Expenditure, 2017-2019
  • Figure 15.54: Thermo Fisher Scientific Inc: SWOT Analysis
  • Figure 15.55: Trivitron Healthcare: Overall Product Offerings
  • Figure 15.56: Trivitron Healthcare: SWOT Analysis
  • Figure 15.57: Unilabs: Overall Product Offerings
  • Figure 15.58: Unilabs: SWOT Analysis